A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects

NCT02003547 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension
Eye Disease

Interventions

DRUG: AMA0076
DRUG: Placebo

Sponsor

Amakem, NV